Related Experiment Video
Updated: Jul 17, 2026
08:23
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
Targeting nitric oxide for cancer therapy.
1School of Pharmacy, Queen's University Belfast, Belfast BT15 4DY, UK. D.Hirst@qub.ac.uk
The Journal of Pharmacy and Pharmacology
|January 18, 2007
Summary
Nitric oxide (NO*) has ideal anticancer properties, influencing tumor growth, blood flow, and immune response. Understanding NO* biology is key to harnessing its potential for enhancing cancer therapies like chemotherapy and radiotherapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Nitric oxide (NO*) possesses properties beneficial for cancer treatment.
- Endogenous NO* levels can paradoxically promote tumor progression.
- A comprehensive understanding of NO* biology is essential for therapeutic applications.
Purpose of the Study:
- To review the multifaceted role of nitric oxide (NO*) in cancer.
- To explore strategies for exploiting NO*'s properties in anticancer therapy.
Main Methods:
- Literature review of NO* in cancer biology and therapy.
- Analysis of NO*'s effects on tumor angiogenesis, metastasis, and immune surveillance.
- Evaluation of NO*'s potential to augment radio- and chemotherapy.
Main Results:
- NO* influences key cancer processes including angiogenesis, metastasis, blood flow, and immune surveillance.
- NO* has the potential to enhance the efficacy of radiotherapy and chemotherapy.
- Achieving optimal NO* levels is critical, as dysregulated endogenous levels can support tumor growth.
Conclusions:
- Nitric oxide (NO*) presents a promising molecular blueprint for anticancer strategies.
- Targeted modulation of NO* offers potential therapeutic benefits in cancer treatment.
- Further research into NO* biochemistry and delivery is warranted for clinical translation.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...